Terms: = Gastric cancer AND LDH
201 results:
1. Integrating serum pharmacochemistry and network pharmacology to explore the molecular mechanisms of Acanthopanax senticosus (Rupr. & Maxim.) Harms on attenuating doxorubicin-induced myocardial injury.
Zhang X; Zhang Q; Yu M; Zhang Y; He T; Qiu Z; Qiu Y; Wang W
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117349. PubMed ID: 38380572
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study.
Li N; Li Z; Fu Q; Zhang B; Zhang J; Wan XB; Lu CM; Wang JB; Deng WY; Ma YJ; Bie LY; Wang MY; Li J; Xia QX; Wei C; Luo SX
Int J Surg; 2024 Apr; 110(4):2071-2084. PubMed ID: 38320099
[TBL] [Abstract] [Full Text] [Related]
3. Anticancer effect of aromatic isoniazid derivatives in human gastric adenocarcinoma cells.
Barathan M; Shivashekaregowda NKH; Hoong SM; Vellasamy KM; Vadivelu J
Toxicol Appl Pharmacol; 2023 Dec; 481():116767. PubMed ID: 38007073
[TBL] [Abstract] [Full Text] [Related]
4. Paclitaxel may inhibit migration and invasion of gastric cancer cells via nod-like receptor family pyrin domain-containing 3/caspase-1/Gasdermin E mediated pyroptosis pathway.
Xu PP; Wu J; Zhang J; Yu TY; Wang YB
Chem Biol Drug Des; 2024 Jan; 103(1):e14325. PubMed ID: 37907334
[TBL] [Abstract] [Full Text] [Related]
5. Structural modification of naturally occurring phenolics as a strategy for developing cytotoxic molecules towards cancer cells.
Olim P; Pereira RB; Fernandes MJG; Natal CM; Coelho JRA; Fortes AG; Gonçalves MST; Pereira DM
Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300294. PubMed ID: 37821361
[TBL] [Abstract] [Full Text] [Related]
6. Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death.
da Silva EL; Mesquita FP; Aragão DR; de Sousa Portilho AJ; Marinho AD; de Oliveira LLB; Lima LB; de Moraes MEA; Souza PFN; Montenegro RC
Toxicol Appl Pharmacol; 2023 Sep; 475():116630. PubMed ID: 37473966
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of clinical and prognostic factors for primary gastric diffuse large B-cell lymphoma: Single-center experience.
Bardakci M; Esmer DD; Hafizoglu E; Karaman K; Kuzu OF; Karakas H; Gungorer B; Uncu D
J Cancer Res Ther; 2023; 19(3):778-782. PubMed ID: 37470610
[TBL] [Abstract] [Full Text] [Related]
8. Amentoflavone attenuates cell proliferation and induces ferroptosis in human gastric cancer by miR-496/ATF2 axis.
Tang F; Xu Y; Gao E; Zhang W; Zhang F; Xiang Y; Xu L; Dong F
Chem Biol Drug Des; 2023 Oct; 102(4):782-792. PubMed ID: 37455326
[TBL] [Abstract] [Full Text] [Related]
9. Outcome and patterns of relapse in primary gastric diffuse large B cell lymphoma treated with RCHOP.
Ma'koseh M; Farfoura H; Abufara A; Elmusa R; Hushki A; Faqeer N; Ghatasheh H; Shahin O; Alawabdeh T; Al-Rwashdeh M; Halahleh K; Al-Ibraheem A; Alrabi K
Hematology; 2023 Dec; 28(1):2198898. PubMed ID: 37114663
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of modified-Gustave-Roussy Immunity Score in resectable proximal gastric cancer.
Shi Y; Ju M; Di X; Sun X; Chen X; He C; Liang L
Medicine (Baltimore); 2023 Mar; 102(12):e33334. PubMed ID: 36961166
[TBL] [Abstract] [Full Text] [Related]
11. Lactate Dehydrogenase and Risk of Readmission with gastric cancer: A Propensity Score Matching Analysis.
Chen WS; Huang ZX; Zhang HH; Chen XD; Cai YQ; Chen WJ; Zhu GB; Huang YS
J Invest Surg; 2023 Dec; 36(1):2172488. PubMed ID: 36775654
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of the clinical characteristics and prognostic factors of gastrointestinal non-Hodgkin lymphoma based on anatomical sites and histological subtype.
Huang T; Wang T; Fang X; Su P; Huang X; Fu H; Liu T
Scand J Gastroenterol; 2023 Jul; 58(7):751-756. PubMed ID: 36740826
[TBL] [Abstract] [Full Text] [Related]
13. Scutellarin Suppressed Proliferation and Induced Apoptosis in gastric cancer via Wnt/β-catenin Signaling Pathway.
Wang Z; Liu X; Chen W; Guo X; Chen L; Wei Z; Liu D; Liu Z
Curr Pharm Des; 2023; 29(5):368-378. PubMed ID: 36717995
[TBL] [Abstract] [Full Text] [Related]
14. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer].
Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667
[No Abstract] [Full Text] [Related]
15. Therapeutic plasma exchange in gastric signet ring cell carcinoma presenting as microangiopathic hemolytic anemia: A rare case report.
Candar O; Ekinci O; Merter M; Aslan M; Aras I
J Clin Apher; 2022 Dec; 37(6):606-610. PubMed ID: 36125111
[TBL] [Abstract] [Full Text] [Related]
16. Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
Rosery V; Mika S; Schmid KW; Reis H; Stuschke M; Treckmann J; Markus P; Schumacher B; Albers D; Mende B; Lahner H; Wiesweg M; Schuler M; Siveke JT; Kasper S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4315-4325. PubMed ID: 36071236
[TBL] [Abstract] [Full Text] [Related]
17. Potential anticancer effect of sodium caprate on human gastric cancer cells.
Kim NH; Park JH; Koo DH; Lee T; Yang JY; Lee HY
Hum Exp Toxicol; 2022; 41():9603271221119182. PubMed ID: 36042573
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Factors in Patients with Advanced HER2-Positive gastric cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study.
Marshall S; Wakatsuki T; Takahari D; Matsushima T; Ishizuka N; Nakayama I; Osumi H; Ogura M; Ichimura T; Shinozaki E; Chin K; Yamaguchi K
J Gastrointest Cancer; 2023 Jun; 54(2):475-484. PubMed ID: 35435573
[TBL] [Abstract] [Full Text] [Related]
19. Differences in glucose concentration shows new perspectives in gastric cancer metabolism.
da Silva EL; Mesquita FP; Portilho AJS; Bezerra ECA; Daniel JP; Aranha ESP; Farran S; de Vasconcellos MC; de Moraes MEA; Moreira-Nunes CA; Montenegro RC
Toxicol In Vitro; 2022 Aug; 82():105357. PubMed ID: 35427737
[TBL] [Abstract] [Full Text] [Related]
20. Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma-a retrospective cohort study.
Kagan KBT; Guz D; Buchrits S; Gurion R; Vaxman I; Priss M; Groshar D; Catalano OA; Sherban A; Raanani P; Gafter-Gvili A; Bernstine H
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2290-2299. PubMed ID: 35079846
[TBL] [Abstract] [Full Text] [Related]
[Next]
